https://www.prnewswire.com/news/calliditas-therapeutics/?page=8
Calliditas Therapeutics News and Press Releases | PR Newswire
news and press releasestherapeuticsnewswire
https://www.calliditas.se/en/
Calliditas Therapeutics AB
Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with...
therapeuticsab
https://www.prnewswire.co.uk/news-releases/calliditas-announces-clinical-development-plan-for-setanaxib-and-comments-on-data-from-part-a-of-nefigard-study-at-today-s-r-amp-d-day-834986258.html
Calliditas announces clinical development plan for setanaxib and comments on data from Part A of...
/PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") (Nasdaq OMX - CALTX) (NASDAQ - CALT) today announced it will provide information on the...
https://www.fiercebiotech.com/biotech/calliditas-liver-disease-trial-hits-primary-endpoint-after-sweeping-changes-design
Calliditas' rethought liver disease trial hits primary endpoint
Jul 26, 2024 - The biotech, which changed the trial to cut costs, only saw a positive trend on liver stiffness and reported a higher rate of dropouts on the drug.
liver diseasetrialhitsprimaryendpoint
https://www.benzinga.com/insights/analyst-ratings/24/05/39119631/critical-insights-from-calliditas-therapeutics-analyst-ratings-what-you-need-to-know
Critical Insights From Calliditas Therapeutics Analyst Ratings: What You Need To Know - Benzinga
what you need to know
https://calliditas.net/
Calliditas – klíč k vědění
k
https://markets.businessinsider.com/news/stocks/calliditas_therapeutics_registered-stock-price-quarter-earnings-preview-q1-1033411539
Here's what to expect from Calliditas Therapeutics Registered's earnings report | Markets Insider
Calliditas Therapeutics Registered will release figures for the most recent quarter on May 23.Wall Street analysts are expecting losses per share ...
what to expect